Reapplix

Reapplix

Produktion af medicinsk udstyr

Birkerød, Birkerød 2.922 følgere

Every wound is personal

Om os

Founded in 2008, Reapplix specializes in the biological treatment and management of diabetic foot ulcers. Its innovative, patented 3C Patch® System draws on the individual patient’s capacity to heal and is clinically proven to accelerate wound healing of chronic diabetic foot ulcers. Headquartered in Denmark, with sales and distribution teams in the US and Europe, Reapplix won the Danish 2018 EY Entrepreneur of the Year Award in the life science category. Our business model is supported by high quality RCT evidence published in The Lancet in September 2018 and a 2019 IWGDF Recommendation. Mission: "Drawing on the person’s power to heal so they can get back to living their best life.” www.reapplix.com

Branche
Produktion af medicinsk udstyr
Virksomhedsstørrelse
11-50 medarbejdere
Hovedkvarter
Birkerød, Birkerød
Type
Privat
Grundlagt
2008
Specialer
Advanced wound care, medical device, wound therapy og PRP

Beliggenheder

Medarbejdere hos Reapplix

Opdateringer

Tilsvarende sider

Finansiering

Reapplix 6 runder i alt

Seneste runde

Serie A

22.858.188,00 US$

Læs mere på crunchbase